PeptidePedia The community reference

Peptide synthesis (revision 1)

Old revision·09:00, 26 Jun 2024·MolarMassMaeve

This is an old revision of this page, as it stood at 09:00, 26 Jun 2024, saved by MolarMassMaeve with the summary new article: supply and handling, expansion welcome. It may differ substantially from the current revision, and any error it contains may since have been corrected.
Peptide synthesis
DirectionC-terminus to N-terminus
Dominant techniqueSolid phase, Fmoc chemistry
AlternativeSolution phase; recombinant expression
Topic infobox · conventions

Peptide synthesis is the chemical assembly of a peptide from protected amino acid building blocks. It proceeds from the C-terminus towards the N-terminus, in the opposite direction to biological translation, because that ordering avoids racemisation of the activated residue.[1]

Chemical synthesis is the only practical route for peptides containing non-proteinogenic residues, and almost every engineered therapeutic peptide contains at least one — the α-aminoisobutyric acid of semaglutide and tirzepatide cannot be introduced by a ribosome.[2]

The elementary cycle

[edit]

Each residue is added by a two-step cycle. The N-terminal protecting group of the growing chain is removed, then the next amino acid — protected at its own N-terminus and on any reactive side chain — is activated and coupled.[1]

Protecting groups are what make selectivity possible. The temporary N-terminal group is removed once per cycle; side-chain groups are orthogonal to it and survive until final cleavage. The choice of scheme — Fmoc with acid-labile side chains, or Boc with more forcing conditions — defines the whole chemistry that follows. See Fmoc chemistry.

References

  1. ^ a b Merrifield RB. "Solid phase peptide synthesis. I. The synthesis of a tetrapeptide." Journal of the American Chemical Society 85(14):2149–2154 (1963). DOI:10.1021/ja00897a025.
  2. ^ Behrendt R, White P, Offer J. "Advances in Fmoc solid-phase peptide synthesis." Journal of Peptide Science 22(1):4–27 (2016). DOI:10.1002/psc.2836. PMID 26785684.